✦ LIBER ✦

PSS7 THE COST-EFFECTIVENESS OF RANIBIZUMAB COMPARED TO PDT-VAND BSC FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN CANADA

✍ Scribed by G Lozano-Ortega; RW Machuk; HE Hass; M Barbeau; MK Mathen

Book ID: 118609596
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 75 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)70902-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTA

PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTANIB (MACUGEN®) AS COMPARED WITH RANIBIZUMAB (LUCENTIS®) FOR TREATING IN AGE-RELATED MACULAR DEGENERATION (AMD)

✍ LY Lu; W McGhan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PSS10 Cost- Effectiveness of Ranibizumab

PSS10 Cost- Effectiveness of Ranibizumab in Patients with Neovascular Wet Age-Related Macular Degeneration (Namd) at the Mexican Social Security System (Imss)

✍ Arreola-Ornelas, H.; Rosado-Buzzo, A.; García-Mollinedo, L.; Dorantes-Aguilar, J 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PSS15 THE COST-EFFECTIVENESS OF RANIBIZU

PSS15 THE COST-EFFECTIVENESS OF RANIBIZUMAB (LUCENTIS®) IN TREATING PATIENTS WITH PREDOMINANTLY CLASSIC, MINIMALLY CLASSIC, AND OCCULT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (AMD)

✍ A Turpcu; JW Hay 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PSS10 COST-EFFECTIVENESS OF ANTIVEGF THE

PSS10 COST-EFFECTIVENESS OF ANTIVEGF THERAPIES FOR WET AGE-RELATED MACULAR DEGENERATION—AMD IN BRAZIL: THE PRIVATE PAYER PERSPECTIVE

✍ RLP Bueno; E Lion 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Effectiveness of intravitreal ranibizuma

Effectiveness of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration in a Canadian retina practice: a retrospective review

✍ Bandukwala, Taha; Muni, Rajeev H.; Schwartz, Carol; Eng, Kenneth T.; Kertes, Pet 📂 Article 📅 2010 🏛 Canadian Ophthalmological Society 🌐 English ⚖ 250 KB

Cost-Effectiveness Analysis of Ranibizum

Cost-Effectiveness Analysis of Ranibizumab versus Verteporfin Photodynamic Therapy, Pegaptanib Sodium, and Best Supportive Care for the Treatment of Age-Related Macular Degeneration in Greece

✍ Kostas Athanasakis; Vasilios Fragoulakis; Vasiliki Tsiantou; Panagiotis Masaouti 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 551 KB